Nick Leschly, President and CEO at 2seventy bio, Inc. (TSVT), bought 368,857 shares at $12.20 ($4.5M) on 2022-03-17, disclosed to the SEC on 2022-03-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TSVT | SELL | 2024-01-05 | $560K | — | Filing → |
| TSVT | SELL | 2023-08-24 | $102K | — | Filing → |
| TSVT | SELL | 2023-08-07 | $111K | — | Filing → |